Rachel Butler served as Senior Vice President of Family Office and Investor relations at Cavendish Global. She managed relationship development for the investor side of the Cavendish community, as well as the programing for Cavendish Global's Impact Forums.

Prior to working at Cavendish Global, Ms. Butler was co-founder and Editor-in-Chief of Asthma Magazine, a direct-to-consumer patient education publication on asthma and allergy.  Asthma Magazine was used by the NHLBI as their primary tool for patient education in their nation-wide children’s asthma study (the CAMP study). The magazine was the source of all patient education materials for the launch of Merck Pharmaceutical’s first-in-class asthma drug, Singulair.  Asthma Magazine was employed in patient education by the American Lung Association, the American Academy of Asthma, Allergy and Immunology, the National Association of School Nurses, health maintenance organizations, disease management companies, and private practitioners throughout the country.

Ms. Butler was instrumental in facilitating the sale of Asthma Magazine to Elsevier Health Sciences, a leading publisher of medical journals, where she continued as Editor-in-Chief for an additional five years.  

Ms. Butler is a trustee and the treasurer of the Ross Conservation Trust. She is married with four children, and is an avid skier, sailor, past competitive figure skater, and a mediocre tennis player.